Platelet-rich plasma application and heterotopic bone formation following total hip arthroplasty

Journal of Investigative Surgery

Volumn 24, Issue 6, 2011, Pages 257-261

  Klaassen, Mark A ^a   Pietrzak, William S ^b,c  

^a OSMC   (United States)

^b Biomet Incorporated   (United States)

^c University of Illinois at Chicago   (United States)

Author keywords

Healing; Heterotopic bone; Ossification; Platelet rich plasma; PRP; Total hip arthroplasty

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HETEROTOPIC OSSIFICATION; HIP OSTEOARTHRITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THROMBOCYTE RICH PLASMA; TOTAL HIP PROSTHESIS;

AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; FEMALE; HUMANS; MALE; MIDDLE AGED; OSSIFICATION, HETEROTOPIC; OSTEOARTHRITIS, HIP; PLATELET-RICH PLASMA; RETROSPECTIVE STUDIES; WOUND HEALING;

EID: 80455131209     PISSN: 08941939     EISSN: 15210553     Source Type: Journal    
DOI: 10.3109/08941939.2011.589885     Document Type: Article

References (28)

1. Vanden Bossche L. Vanderstraeten G, Heterotopic ossification: A review. J RehabilMed. 2005;37:129-136.
2. Nilsson OS, Persson P-E. Heterotopic bone formation after joint replacement. Curr Opin Rheumatol. 1999;11:127-131.
3. Back DL, Smith JD, Dalziel RE, et al. Incidence of heterotopic ossification after hip resurfacing. ANZ J Surg. 207;77:642-647.
4. Iorio R, Healy WL. Heterotopic ossification after hip and knee arthroplasty: Risk factors, prevention, and treatment. J Am Acad Orthop Surg. 2002;10:409-416.
5. Neal B, Gray H,MacMahon S, Dunn L. Incidence of heterotopic bone formation after major hip surgery. ANZ J Surg. 2002;72:808-821.
6. Brooker AF, Bowerman JW, Robinson RA, et al. Ectopic ossification following total hip replacement. J Bone Joint Surg Am. 1973;55-A:1629-1632.
7. McCarthy EF, Sundaram M. Heterotopic ossification: A review. Skeletal Radiol. 2005;34:609-619.
8. Mann HA, Choudhury MZB, Lee CA, et al. Heterotopic bone formation as a complication of elective joint replacement in haemophilic patients - A case report and literature review. Haemophilia. 2006;12:672-675.
9. Ashton LA, Bruce W, Goldberg J, et al., Prevention of heterotopic bone formation in high risk patients post-total hip arthroplasty J Orthop Surg. 2000; 8:53-57.
10. Ebinger T, Roesch M, Kiefer H, et al. Influence of etiology in heterotopic bone formation of the hip. J Trauma. 2000;48:1058-1062.
11. Pietrzak WS, Eppley BL. Platelet rich plasma: Biology and new technology. J Craniofac Surg. 2005;16:1043-1054.
12. Woodell-May JE, Pietrzak WS. Platelet-rich plasma in orthopedics. In: Muscoloskeletal Tissue Regeneration: Biological Materials and Methods. Pietrzak WS, ed. Humana Press, Totowa, NJ: 2008:547-658.
13. Balboni TA, Gobezie R, Mamon HJ. Heterotopic ossification: Pathophysiology, clinical features, and the role of radiotherapy for prophylaxia. Int J Radiat Oncol Biol Phys. 2006;65:1289-1299.
14. Toom A, Arend A, Gunnarsson D, et al. Bone formation zones in heterotopic ossifications: Histologic findings and increased expression of bone morphogenetic protein 2 and transforming growth factors β2 and β3. Calcif Tissue Int. 2007;80:259-267.
15. Ekbäck G, Ryttberg L, Axelsson K, et al. Preoperative platelet-rich plasmapheresis and hemodilution with an autotransfusion device in total hip replacement surgery. J Clin Apher. 2000;15:256-261.
16. Ekbäck G, Edlund B, Smolowicz A, et al. The effects of platelet apheresis in total hip replacement surgery on platelet activation. Acta Anaesthesiol Scand. 2002;46:68-73.
17. Berghoff WJ, Pietrzak WS, Rhodes RD, Platelet-rich plasma application during closure following total knee arthroplasty. Orthopedics. 2006;29:590-598.
18. Ritter MA, Vaughan RB. Ectopic ossification after total hip arthroplasty. J Bone Joint Surg Am. 1977;59-A:345-351.
19. Sawyer JR, Myers MA, Rosier RN, et al. Heterotopic ossification: Clinical and cellular aspects. Calcif Tissue Int. 1991;49:208-215.
20. Schara K, Herman S. Heterotopic bone formation in total hip arthroplasty: Predisposing factors, classification, and the significance for clinical outcome. Acta Chir Orthop. 2001;68:105-108.
21. Wilkinson JM, Stockley I, Hamer AJ, et al. Biochemical markers of bone turnover and development of heterotopic ossification after total hip arthroplasty. J Orthop Res. 2003;21:529-534.
22. Prandit A, Ashar R, Feldman D, The effect of TGF-β delivered through a collagen scaffold on wound healing. J Invest Surg. 1999;12:89-100.
23. Eppley BL, Woodell JE, Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: Implications for wound healing. Plast Reconstr Surg. 2004;114:1502-1508.
24. Ranly DM, Lohmann CH, Andreacchio D, et al. Plateletrich plasma inhibits demineralized bone matrix-induced bone formation in nude mice. J Bone Joint Surg Am. 2007;89- A:139-147.
25. Han B, Woodell-May JE, Ponticiello M, et al. The effect of thrombin activation of platelet-rich plasma on demineralized bone matrix osteonductivity. J Bone Joint Surg Am. 2009;91:1459-1470.
26. Sipe JB, Waits CA, Skikne B, et al. The presence of bone morphogenetic proteins (BMPs) in megakaryocytes and platelets. Presented at the Annual Meeting. September 20-24, 2002; American Society for Bone and Mineral Research; San Antonio, TX.
27. Christie RJ, Carrington L, Alving B. Postoperative bleeding induced by topical bovine thrombin: Report of two cases. Surgery. 1997;121:708-710.
28. Zehnder JL, Leung LL. Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin. Blood. 1990;76:2011-2016.